Global

Jul 08, 2009
By Pharmaceutical Executive Editors
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
Jun 17, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales.
May 06, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a "risk radar" to your organization.
Apr 01, 2009
By Pharmaceutical Executive Editors
A new report by the Royal College of Physicians breaks down the reasons why patients are disillusioned about access to medicines, and documents a steady growth in the lack of trust between industry and the NHS. More importantly, it gives recommendations on how to solve the problems.
Mar 11, 2009
It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.
Oct 01, 2007
Pharmaceutical Executive
The first wealth is health, wrote American thinker Ralph Waldo Emerson. Indeed, history has taught us (even before Emerson) that health and wealth are inextricably linked—the more money one has, the healthier one is likely to be.
Jul 25, 2007
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Tainted batches of Viracept pulled from European shelves.
Jan 01, 2007
Pharmaceutical Executive
A free flow of cheap counterfeits eclipses the ability of local manufacturers to create new products.
Oct 01, 2006
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A new European collaboration of biotech, pharma, academia, and government takes up the challenge of boosting R&D.
native1_300x100
lorem ipsum